Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share details the company saw record revenue as they release their Q3 financial numbers. The company showing revenues of 5.7 million for Q3 2021 which is up 280% over Q3 2020. They also have enjoyed record gross margin of $2.2 million, up 1602% over Q3 2020.
Saviuk telling Proactive the company also saw record gross margins of $2.2 million, up 1602% over Q3 2020 and 204% over the prior quarter.